Cargando…
Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro
BACKGROUND: Occurring frequently after solid organ and hematopoietic stem cell transplantation, cytomegalovirus (CMV) replication remains a relevant cause of mortality and morbidity in affected patients. Despite these adverse effects, an increased alloreactivity of natural killer (NK) cells after CM...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087575/ https://www.ncbi.nlm.nih.gov/pubmed/27830183 http://dx.doi.org/10.1097/TXD.0000000000000605 |
_version_ | 1782463944658518016 |
---|---|
author | Tschan-Plessl, Astrid Stern, Martin Schmied, Laurent Retière, Christelle Hirsch, Hans H. Garzoni, Christian van Delden, Christian Boggian, Katia Mueller, Nicolas J. Berger, Christoph Villard, Jean Manuel, Oriol Meylan, Pascal Terszowski, Grzegorz |
author_facet | Tschan-Plessl, Astrid Stern, Martin Schmied, Laurent Retière, Christelle Hirsch, Hans H. Garzoni, Christian van Delden, Christian Boggian, Katia Mueller, Nicolas J. Berger, Christoph Villard, Jean Manuel, Oriol Meylan, Pascal Terszowski, Grzegorz |
author_sort | Tschan-Plessl, Astrid |
collection | PubMed |
description | BACKGROUND: Occurring frequently after solid organ and hematopoietic stem cell transplantation, cytomegalovirus (CMV) replication remains a relevant cause of mortality and morbidity in affected patients. Despite these adverse effects, an increased alloreactivity of natural killer (NK) cells after CMV infection has been assumed, but the underlying physiopathological mechanisms have remained elusive. METHODS: We used serial analyses of NK cells before and after CMV infection in kidney transplant recipients as an in vivo model for CMV primary infection to explore the imprint of CMV infection using every patient as their own control: We analyzed NK cell phenotype and function in 47 CMV seronegative recipients of CMV seropositive kidney grafts, who developed CMV primary infection posttransplant. Seronegative recipients of seronegative kidney grafts served as controls. RESULTS: We observed a significant increase of NKG2C expressing NK cells after CMV infection (mean increase, 17.5%; 95% confidence interval [95% CI], 10.2-24.9, P < 0.001), whereas cluster of differentiation (CD)57 expressing cells decreased (mean decrease, 14.1%; 95% CI, 8.0-20.2; P < 0.001). Analysis of killer immunoglobulin-like receptor (KIR) expression showed an increase of cells expressing KIR2DL1 as their only inhibitory KIR in patients carrying the cognate ligand HLA-C2 (mean increase, 10.0%; 95% CI, 1.7-18.3; P = 0.018). In C2-negative individuals, KIR2DL1 expression decreased (mean decrease, 3.9%; 95% CI, 1.6-6.2; P = 0.001). As for activating KIR, there was no conclusive change pattern. Most importantly, we observed a significantly higher NK cell degranulation and IFNγ production in response to different target cells (target K562, CD107a: mean increase, 9.9%; 95% CI, 4.8-15.0; P < 0.001; IFNγ: mean increase, 6.6%; 95% CI, 1.6-11.1; P < 0.001; target MRC-5, CD107a: mean increase, 6.9%; 95% CI, 0.7-13.1; P = 0.03; IFNγ: mean increase, 4.8%; 95% CI, 1.7-7.8; P = 0.002). CONCLUSIONS: We report evidence for an increased function of NK cells induced by CMV infection. This increased in vitro functionality was seen in NKG2C-positive and NKG2C-negative subsets, arguing for an NKG2C independent mechanism of action. |
format | Online Article Text |
id | pubmed-5087575 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-50875752017-03-27 Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro Tschan-Plessl, Astrid Stern, Martin Schmied, Laurent Retière, Christelle Hirsch, Hans H. Garzoni, Christian van Delden, Christian Boggian, Katia Mueller, Nicolas J. Berger, Christoph Villard, Jean Manuel, Oriol Meylan, Pascal Terszowski, Grzegorz Transplant Direct Kidney Transplantation BACKGROUND: Occurring frequently after solid organ and hematopoietic stem cell transplantation, cytomegalovirus (CMV) replication remains a relevant cause of mortality and morbidity in affected patients. Despite these adverse effects, an increased alloreactivity of natural killer (NK) cells after CMV infection has been assumed, but the underlying physiopathological mechanisms have remained elusive. METHODS: We used serial analyses of NK cells before and after CMV infection in kidney transplant recipients as an in vivo model for CMV primary infection to explore the imprint of CMV infection using every patient as their own control: We analyzed NK cell phenotype and function in 47 CMV seronegative recipients of CMV seropositive kidney grafts, who developed CMV primary infection posttransplant. Seronegative recipients of seronegative kidney grafts served as controls. RESULTS: We observed a significant increase of NKG2C expressing NK cells after CMV infection (mean increase, 17.5%; 95% confidence interval [95% CI], 10.2-24.9, P < 0.001), whereas cluster of differentiation (CD)57 expressing cells decreased (mean decrease, 14.1%; 95% CI, 8.0-20.2; P < 0.001). Analysis of killer immunoglobulin-like receptor (KIR) expression showed an increase of cells expressing KIR2DL1 as their only inhibitory KIR in patients carrying the cognate ligand HLA-C2 (mean increase, 10.0%; 95% CI, 1.7-18.3; P = 0.018). In C2-negative individuals, KIR2DL1 expression decreased (mean decrease, 3.9%; 95% CI, 1.6-6.2; P = 0.001). As for activating KIR, there was no conclusive change pattern. Most importantly, we observed a significantly higher NK cell degranulation and IFNγ production in response to different target cells (target K562, CD107a: mean increase, 9.9%; 95% CI, 4.8-15.0; P < 0.001; IFNγ: mean increase, 6.6%; 95% CI, 1.6-11.1; P < 0.001; target MRC-5, CD107a: mean increase, 6.9%; 95% CI, 0.7-13.1; P = 0.03; IFNγ: mean increase, 4.8%; 95% CI, 1.7-7.8; P = 0.002). CONCLUSIONS: We report evidence for an increased function of NK cells induced by CMV infection. This increased in vitro functionality was seen in NKG2C-positive and NKG2C-negative subsets, arguing for an NKG2C independent mechanism of action. Lippincott Williams & Wilkins 2016-06-17 /pmc/articles/PMC5087575/ /pubmed/27830183 http://dx.doi.org/10.1097/TXD.0000000000000605 Text en Copyright © 2016 The Authors. Transplantation Direct. Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
spellingShingle | Kidney Transplantation Tschan-Plessl, Astrid Stern, Martin Schmied, Laurent Retière, Christelle Hirsch, Hans H. Garzoni, Christian van Delden, Christian Boggian, Katia Mueller, Nicolas J. Berger, Christoph Villard, Jean Manuel, Oriol Meylan, Pascal Terszowski, Grzegorz Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro |
title | Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro |
title_full | Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro |
title_fullStr | Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro |
title_full_unstemmed | Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro |
title_short | Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro |
title_sort | human cytomegalovirus infection enhances nk cell activity in vitro |
topic | Kidney Transplantation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087575/ https://www.ncbi.nlm.nih.gov/pubmed/27830183 http://dx.doi.org/10.1097/TXD.0000000000000605 |
work_keys_str_mv | AT tschanplesslastrid humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT sternmartin humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT schmiedlaurent humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT retierechristelle humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT hirschhansh humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT garzonichristian humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT vandeldenchristian humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT boggiankatia humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT muellernicolasj humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT bergerchristoph humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT villardjean humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT manueloriol humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT meylanpascal humancytomegalovirusinfectionenhancesnkcellactivityinvitro AT terszowskigrzegorz humancytomegalovirusinfectionenhancesnkcellactivityinvitro |